823 Repurposing CD26/DPP4 inhibitors to enhance immunotherapy response in pancreatic ductal adenocarcinoma

Bibliographic Details
Main Authors: Thomas Mace, Gregory B Lesinski, Chrystal M Paulos, Michael Ware, Olatunji Alese, Juan Sarmiento, Shishir Maithel, Maggie Phillips, Megan M Wyatt, Natalie K Horvat, Jacklyn Hammons, Bassel FEl Reyes
Format: Article
Language:English
Published: BMJ Publishing Group 2023-11-01
Series:Journal for ImmunoTherapy of Cancer
_version_ 1797383228412133376
author Thomas Mace
Gregory B Lesinski
Chrystal M Paulos
Michael Ware
Olatunji Alese
Juan Sarmiento
Shishir Maithel
Maggie Phillips
Megan M Wyatt
Natalie K Horvat
Jacklyn Hammons
Bassel FEl Reyes
author_facet Thomas Mace
Gregory B Lesinski
Chrystal M Paulos
Michael Ware
Olatunji Alese
Juan Sarmiento
Shishir Maithel
Maggie Phillips
Megan M Wyatt
Natalie K Horvat
Jacklyn Hammons
Bassel FEl Reyes
author_sort Thomas Mace
collection DOAJ
first_indexed 2024-03-08T21:17:53Z
format Article
id doaj.art-ec528f048f7847a9b25e2cd153a50053
institution Directory Open Access Journal
issn 2051-1426
language English
last_indexed 2024-03-08T21:17:53Z
publishDate 2023-11-01
publisher BMJ Publishing Group
record_format Article
series Journal for ImmunoTherapy of Cancer
spelling doaj.art-ec528f048f7847a9b25e2cd153a500532023-12-21T14:40:08ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262023-11-0111Suppl 110.1136/jitc-2023-SITC2023.0823823 Repurposing CD26/DPP4 inhibitors to enhance immunotherapy response in pancreatic ductal adenocarcinomaThomas Mace0Gregory B Lesinski1Chrystal M Paulos2Michael Ware3Olatunji Alese4Juan Sarmiento5Shishir Maithel6Maggie Phillips7Megan M Wyatt8Natalie K Horvat9Jacklyn Hammons10Bassel FEl Reyes113The Ohio State University, Columbus, OH, USAEmory University, Atlanta, GA, USAEmory University, Atlanta, GA, USA2NeoImmuneTech, Inc., Snellville, GA, USA4Winship Cancer Institute at Emory University, Atlanta, GA, USA1Emory University, Atlanta, GA, USA1Emory University, Atlanta, GA, USA1Emory University, Atlanta, GA, USAEmory University, Atlanta, GA, USAEmory University, Atlanta, GA, USAEmory University, Atlanta, GA, USA5University of Alabama at Birmingham Medical Center, Birmingham, AL, USA
spellingShingle Thomas Mace
Gregory B Lesinski
Chrystal M Paulos
Michael Ware
Olatunji Alese
Juan Sarmiento
Shishir Maithel
Maggie Phillips
Megan M Wyatt
Natalie K Horvat
Jacklyn Hammons
Bassel FEl Reyes
823 Repurposing CD26/DPP4 inhibitors to enhance immunotherapy response in pancreatic ductal adenocarcinoma
Journal for ImmunoTherapy of Cancer
title 823 Repurposing CD26/DPP4 inhibitors to enhance immunotherapy response in pancreatic ductal adenocarcinoma
title_full 823 Repurposing CD26/DPP4 inhibitors to enhance immunotherapy response in pancreatic ductal adenocarcinoma
title_fullStr 823 Repurposing CD26/DPP4 inhibitors to enhance immunotherapy response in pancreatic ductal adenocarcinoma
title_full_unstemmed 823 Repurposing CD26/DPP4 inhibitors to enhance immunotherapy response in pancreatic ductal adenocarcinoma
title_short 823 Repurposing CD26/DPP4 inhibitors to enhance immunotherapy response in pancreatic ductal adenocarcinoma
title_sort 823 repurposing cd26 dpp4 inhibitors to enhance immunotherapy response in pancreatic ductal adenocarcinoma
work_keys_str_mv AT thomasmace 823repurposingcd26dpp4inhibitorstoenhanceimmunotherapyresponseinpancreaticductaladenocarcinoma
AT gregoryblesinski 823repurposingcd26dpp4inhibitorstoenhanceimmunotherapyresponseinpancreaticductaladenocarcinoma
AT chrystalmpaulos 823repurposingcd26dpp4inhibitorstoenhanceimmunotherapyresponseinpancreaticductaladenocarcinoma
AT michaelware 823repurposingcd26dpp4inhibitorstoenhanceimmunotherapyresponseinpancreaticductaladenocarcinoma
AT olatunjialese 823repurposingcd26dpp4inhibitorstoenhanceimmunotherapyresponseinpancreaticductaladenocarcinoma
AT juansarmiento 823repurposingcd26dpp4inhibitorstoenhanceimmunotherapyresponseinpancreaticductaladenocarcinoma
AT shishirmaithel 823repurposingcd26dpp4inhibitorstoenhanceimmunotherapyresponseinpancreaticductaladenocarcinoma
AT maggiephillips 823repurposingcd26dpp4inhibitorstoenhanceimmunotherapyresponseinpancreaticductaladenocarcinoma
AT meganmwyatt 823repurposingcd26dpp4inhibitorstoenhanceimmunotherapyresponseinpancreaticductaladenocarcinoma
AT nataliekhorvat 823repurposingcd26dpp4inhibitorstoenhanceimmunotherapyresponseinpancreaticductaladenocarcinoma
AT jacklynhammons 823repurposingcd26dpp4inhibitorstoenhanceimmunotherapyresponseinpancreaticductaladenocarcinoma
AT basselfelreyes 823repurposingcd26dpp4inhibitorstoenhanceimmunotherapyresponseinpancreaticductaladenocarcinoma